The Board of Directors of Claranova (Euronext Paris: FR0013426004 – CLA or the “Company”), meeting on October 28, 2025, has decided to submit to the next Combined General Meeting of Shareholders, to be held on December 10, 2025, as part of its ordinary session, the approval of the proposed transfer of its securities from the regulated market of Euronext Paris (Compartment C) to the multilateral trading facility of Euronext Growth Paris.
The combined general meeting of shareholders of Claranova (Euronext Paris: FR0013426004 – CLA or the “Company”), held today, approved, in accordance with the provisions of Article L. 421-14 of the French Commercial Code, the proposed transfer of its shares from the regulated market of Euronext Paris (Compartment C) to the market of Euronext Growth Paris, and granted full powers to the Board of Directors to implement this transfer of listing.
The Board of Directors, which also met today following the Combined Shareholders’ Meeting, decided to implement this transfer.
Reasons for the proposed transfer
As announced on October 29, 2025, this project reflects a pragmatic approach to managing resources and costs by reducing regulatory compliance requirements and obligations and, in so doing, optimizing listing costs. The resources and means thus made available will be in turn fully redeployed towards implementing the strategic plan for increasing revenue and improving profitability.
Euronext Growth is a well-established, attractive and liquid market, with over 600 listed companies, including many technology companies. Claranova would be listed among comparable stocks on the Euronext Growth market, in that way enhancing its visibility and attractiveness. This transfer is a natural evolution towards a framework more adapted to its current size, maturity, and stock market profile. On that basis, it represents a judicious choice in favor of operational performance and shareholder interests.
This new flexibility would also give Claranova greater agility to implement its strategic priorities, including in particular continuing to reduce its debt and simplifying the scope of its activities. Claranova remains fully committed to maintaining regular dialogue with its shareholders and investors.
Details of the transfer project
This transfer entails submitting a request to Euronext Paris S.A. to delist its shares from the Euronext Paris regulated market and simultaneously list them on the Euronext Growth Paris multilateral trading facility.
Subject to the agreement of Euronext Paris S.A., the shares will be admitted to trading under an accelerated procedure as a direct listing that does not entail the issuance of new shares
The Company currently meets the eligibility requirements for the transfer procedure, namely a market capitalization of less than €1 billion and a minimum public float of €2.5 million. These conditions must also be met on the day the transfer is requested. The Company is also up to date with its disclosure obligations on the Euronext Paris regulated market.
No actions will be required by holders of Claranova shares, whether bearer or registered, in connection with this transfer.
The costs associated with this transfer are set by Euronext according to an official scale and will be fully offset by the savings achieved in the first year of the Euronext Growth listing.
In the event that Claranova shares are transferred to the Euronext Growth Paris market, they will no longer be eligible for the Deferred Settlement Service (SRD).
For its transfer to Euronext Growth Paris, Claranova will be assisted by SwissLife Banque Privée as Listing Sponsor.